Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

Introduction A clinical trial evaluated ocular hypotensive efficacy and safety of netarsudil 0.02% once daily (QD) relative to ripasudil 0.4% twice daily (BID). Methods This was a single-masked, randomized, phase 3, superiority study. Japanese patients were randomized to either the netarsudil 0.02%...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Advances in therapy 2023-10, Vol.40 (10), p.4639-4656
Hauptverfasser:	Araie, Makoto, Sugiyama, Kazuhisa, Aso, Kenji, Kanemoto, Koji, Iwata, Ryo, Hollander, David A., Senchyna, Michelle, Kopczynski, Casey C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Endocrinology Internal Medicine Medicine Medicine & Public Health NCT NCT04620135 Oncology Original Research Pharmacology/Toxicology Rheumatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!